Cell Culture Media Market Analysis

Type (Liquid Media, Semi-Solid Media, Solid Media)

The global cell culture media market is segmented and analyzed for demand and supply by type into liquid media, semi-solid media, and solid media. Out of the three types of cell culture media, the liquid segment is estimated to gain the largest market share of about 38% in the year 2037. The growth of the segment can be attributed to the rising investment in the pharmaceutical sector as well as the increasing collaborations amongst major players as well as R&D in the field of life sciences for novel drug development and therapeutic research. For instance, recently in March 2023, Nucleus Biologics, The Cell Performance Company, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, in a joint effort to accelerate high-quality therapies to market, announced plans for a supply agreement with the Center for Breakthrough Medicines (CBM), leading contract development and manufacturing organization (CDMO). The mission of CDMO is to save lives by accelerating the development and manufacture of advanced therapies.

End-user (Hospitals & Diagnostic Laboratories, Pharmaceutical)

The global cell culture media market is also segmented and analyzed for demand and supply by end-user into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, research & academic institutes, and others. Amongst these segments, the pharmaceutical & biotechnology segment is expected to garner a significant share of around 46% in the year 2037. The rising share of sales of biotechnology drugs worldwide which amounted to over USD 400 billion in 2022 is anticipated to boost the segment growth. On the other hand, the research & academics segment is projected to witness a massive CAGR during the forecast period, owing to the increasing research and development proficiencies in the direction of cell culture media along with the rising advancement in stem cell therapies. This, as a result, is also anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

By Type	Liquid Media Semi-Solid Media Solid Media
By Product	Serum-Free Media Classical Media Stem Cell Culture Media Specialty Media Others
By Application	Biopharmaceutical Production Vaccines Production Monoclonal Antibodies Other Therapeutic Proteins Diagnostics Drug Screening & Development Tissue Engineering & Regenerative Medicine Cell & Gene Therapy Other Tissue Engineering & Regenerative Medicine Applications Others
By End User	Hospitals & Diagnostic Laboratories Pharmaceutical & Biotechnology Companies Research & Academic Institutes Others

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell culture media is assessed at USD 7.7 billion.

The cell culture media market size was over USD 6.98 billion in 2024 and is poised to reach USD 32.37 billion by the end of 2037, witnessing around 12.8% CAGR during the forecast period i.e., between 2025-2037. The increasing research in the field of molecular biology as well as the growing R&D spending by biopharma companies along with rising development in the genome industry will boost the market growth.

North American industry is expected to be the largest 35% share by 2037, due to the growing investment in the biopharmaceutical sector as well as growing advancements in the field of gene therapy, tissue engineering, production of vaccines, antibiotics, and artificial hormones in the region.

The major players in the market include Thermo Fisher Scientific Inc., Corning Incorporated, Sigma-Aldrich Co., Merck KGaA, Becton, Dickinson, and Company, Cell Culture Technologies, PromoCell GmbH, VWR International, LLC, Bio-Rad Laboratories, Inc., Fujifilm Holdings Corporation, Sartorius AG.

Cell Culture Media Market Analysis